Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

A MEMS-based atomic force microscope developed by engineers at UT Dallas is about 1 square centimeter in size (top center). Here it is attached to a small printed circuit board that contains circuitry, sensors and other miniaturized components that control the movement and other aspects of the device. (Image Credit: The University of Texas at Dallas)

Read more ...

Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share. Hologic, a leader in women's health, and Cynosure, a leader in medical aesthetics systems and technologies, announced today they have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.

Read more ...

The prestigious Institute of Ocular Microsurgery in Barcelona implanted the first patient in Spain with IRIS® II, a bionic vision system equipped with a bio-inspired camera and a 150-electrode epi-retinal implant that is designed to be explantable.

Read more ...

Prototyping of microfluidic devices presents a number of challenges. Fabrication techniques such as clean room-based microfabrication, injection molding and milling and bonding are generally slow and expensive, and traditional 3D printers are unable to generate fluidically-sealed devices able to cope with the high pressures required. In addition, conventional 3D printing materials are unsuitable for microfluidic applications, as they are not chemically or biologically compatible, or transparent. Until now, this has prevented the adoption of 3D printing technology for microfluidic applications.

Read more ...

A University of Glasgow research project is set to get underway beyond the earth's atmosphere following a successful launch into space. The project could help future space explorers create their own chemicals and drugs on demand, allowing them to maximise the efficiency of their launch payloads by taking raw chemical ingredients with them rather than specific medications. They could then use digital chemistry technology to make drugs and other materials as required.

Read more ...

Cepheid announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert® Xpress Flu and Xpert Xpress Flu/RSV. Both tests deliver reference-quality molecular results in as little as twenty minutes. The tests are Cepheid's first Xpress branded products — all of which are expected to deliver results in 30 minutes or less.

Read more ...

Upcoming Events


> Lab-on-a-Chip & Microfluidics 2017
(May 10 - May 11, Munich, Germany)